☰

Fatima Teixeira-clerc - Publications

Affiliations: 
UPMC Univ Paris 6, France 
Tree Info Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Mallat A, Teixeira-Clerc F, Lotersztajn S. Cannabinoid signaling and liver therapeutics. Journal of Hepatology. 59: 891-6. PMID 23567085 DOI: 10.1016/j.jhep.2013.03.032  0.422
2011 Mallat A, Teixeira-Clerc F, Deveaux V, Manin S, Lotersztajn S. The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings. British Journal of Pharmacology. 163: 1432-40. PMID 21457226 DOI: 10.1111/j.1476-5381.2011.01397.x  0.374
2010 Teixeira-Clerc F, Belot M-, Manin S, Deveaux V, Zimmer A, Tordjmann T, Mallat A, Lotersztajn S. 989 Beneficial Paracrine Effects Of Cannabinoid Cb2 Receptors On Liver Injury And Regeneration Journal of Hepatology. 52. DOI: 10.1016/S0168-8278(10)60990-7  0.374
2010 Louvet A, Teixeira-Clerc F, Deveaux V, Chobert M, Pavoine C, Mallat A, Lotersztajn S. 791 BENEFICIAL EFFECTS OF CANNABINOID RECEPTOR 2 ON ALCOHOLIC LIVER DISEASE Journal of Hepatology. 52: S307-S308. DOI: 10.1016/S0168-8278(10)60793-3  0.329
2009 Belot M-, Teixeira-Clerc F, Manin S, Deveaux V, Nhieu Jtv, Zimmer A, Mallat A, Lotersztajn S. 108 Cannabinoid Cb2 Receptors Stimulate Liver Regeneration Journal of Hepatology. 50. DOI: 10.1016/S0168-8278(09)60110-0  0.428
2008 Lotersztajn S, Teixeira-Clerc F, Julien B, Deveaux V, Ichigotani Y, Manin S, Tran-Van-Nhieu J, Karsak M, Zimmer A, Mallat A. CB2 receptors as new therapeutic targets for liver diseases. British Journal of Pharmacology. 153: 286-9. PMID 17952109 DOI: 10.1038/Sj.Bjp.0707511  0.449
2006 Teixeira-Clerc F, Julien B, Grenard P, Tran Van Nhieu J, Deveaux V, Li L, Serriere-Lanneau V, Ledent C, Mallat A, Lotersztajn S. [CB1 cannabinoid receptor antagonists: a novel approach for the treatment of liver fibrosis]. Medecine Sciences : M/S. 22: 683-5. PMID 16962033 DOI: 10.1051/medsci/20062289683  0.428
2006 Teixeira-Clerc F, Julien B, Grenard P, Tran Van Nhieu J, Deveaux V, Li L, Serriere-Lanneau V, Ledent C, Mallat A, Lotersztajn S. CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nature Medicine. 12: 671-6. PMID 16715087 DOI: 10.1038/nm1421  0.36
2005 Julien B, Grenard P, Teixeira-Clerc F, Van Nhieu JT, Li L, Karsak M, Zimmer A, Mallat A, Lotersztajn S. Antifibrogenic role of the cannabinoid receptor CB2 in the liver Gastroenterology. 128: 742-755. PMID 15765409 DOI: 10.1053/J.Gastro.2004.12.050  0.381
2003 Teixeira-Clerc F, Michalet S, Ménez A, Kessler P. A cysteine-linkable, short cleavable photoprobe with dual functionality to explore protein-protein interfaces. Bioconjugate Chemistry. 14: 554-62. PMID 12757379 DOI: 10.1021/bc0256502  0.465
2002 Teixeira-Clerc F, Ménez A, Kessler P. How do short neurotoxins bind to a muscular-type nicotinic acetylcholine receptor? The Journal of Biological Chemistry. 277: 25741-7. PMID 12006581 DOI: 10.1074/Jbc.M200534200  0.4
Show low-probability matches.